BRCA1 and triple-negative breast carcinoma: Interestingly, a study carried out on 237 triple-negative breast cancer (TNBC) cases indicated that the promoter hypermethylation of BRCA1 is more frequent than BRCA1 germline mutations, suggesting that both alterations can independently drive malignant breast tumorigenesis [8].